Key factors
sym | RTIX |
exch | US |
MCap | 234.24M |
Beta | 2.031 |
EPS | -0.05 |
Div date | 0000-00-00 |
Yesterday
sym | RTIX |
exch | US |
close | 1.7 |
50 Day MA | 2.249 |
200 Day MA | 2.291 |
Target Price | 5.5 |
Market Cap Mln | 234.24 |
Share statistics
Shares Outstanding | 74.60M |
Shares Float | 57.70M |
Percent Institutions | 79.57 |
PercentInsiders | 11.17 |
SharesShort | 1347.93K |
Short Ratio | 2.53 |
Shares Short Prior Month | 966.45K |
Short Percent | 1.879 |
Income
Revenue TTM | 284.76M |
Revenue Per Share TTM | 3.766 |
Quarterly Revenue Growth YOY | -34.0 |
Gross Profit TTM | 174.71M |
EBITDA | 13.67M |
Diluted Eps TTM | -3.42 |
earning
Operating Margin TTM | -0.09 |
PEGRatio | 5.39 |
EPS Estimate Current Quarter | -0.27 |
EPS Estimate Current Year | -0.74 |
EPS Estimate Next Year | -0.24 |
Earnings Share | -0.05 |
Dividend
Dividend Date | 0000-00-00 |
Last Split Date | 0000-00-00 |
business
Enterprise Value Ebitda | 56.85 |
Enterprise Value Revenue | 0.282 |
Book Value /share | 0.234 |
Price Book MRQ | 1.607 |
Price Sales TTM | 0.554 |
ProfitMargin | -0.90 |
ReturnOnAssetsTTM | -0.03 |
Sector
Gic Group | Health Care Equipment & Services |
Gic Industry | Health Care Equipment & Supplies |
Gic Sector | Health Care |
Gic Sub Industry | Health Care Supplies |
Industry | Medical Devices |
Sector | Healthcare |
Codes
ISIN | US74975N1054 |
CIK | 1760173 |
Code | RTIX |
CUSIP | 75886N100 |
Employer Id Number | 59-3466543 |
CountryISO | US |
Currency Code | USD |
Currency Name | US Dollar |
Exchange | NASDAQ |
Currency Symbol | $ |
fund
Type | Common Stock |
UpdatedAt | 2021-01-28 |
is Delisted | 1 |
Delisted Date | 2020-07-22 |
Home Category | Domestic |
info
Fiscal Year End | December |
ForwardPE | 526.31 |
Full Time Employees | 935.0 |
IPODate | 2000-08-10 |
International Domestic | Domestic |
MostRecent Quarter | 2020-09-30 |
Contact
Name | RTI Surgical Holdings Inc |
Address | 520 Lake Cook Road, Deerfield, IL, United States, 60015 |
Country Name | USA |
Phone | 877 343 6832 |
Web URL | www.rtix.com |
Logo URL | /img/logos/US/RTIX.png |
Surgalign Holdings, Inc., a medical technology company, designs, develops, manufactures, and distributes biologic, metal, and synthetic implants worldwide. It offers coflex interlaminar stabilization device, an implant for the treatment of moderate to severe lumbar spinal stenosis in conjunction with decompression; SImmetry sacroiliac joint fusion system, which decreases in opioid use, pain, and disability; and Fortilink IBF system with TETRAfuse ?3D technology. The company's implants are used in the fields of orthopedic, spine, sports medicine, plastic surgery, trauma, and other surgical procedures to repair and promote the natural healing of human bone and other human tissues; and to enhance surgical outcomes. It markets its products through its direct distribution force and various OEM relationships to healthcare providers, hospitals, and other healthcare facilities, as well as through a network of independent distributors. The company was founded in 1997 and is headquartered in Deerfield, Illinois.